Drugs / Fixed-dose trace element combination product of zinc, copper, and selenious acid
Fixed-dose trace element combination product of zinc, copper, and selenious acid
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT05661682 Comparator | Feb → Oct 2025 | — | American Regent, Inc. | Withdrawn | No outcome recorded Stop: Enrollment |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fixed-dose trace element combination product of zinc, copper, and selenious acid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05661682 ↗ |